Skip to content

Maxillary Nerve Blocks in Children - An MRI Study of the Suprazygomatic Approach

Maxillary Nerve Blocks in Children - An MRI Study of the Suprazygomatic

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05778903
Enrollment
20
Registered
2023-03-21
Start date
2023-06-07
Completion date
2024-12-31
Last updated
2024-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Cleft Palate, Nerve Block

Brief summary

Ultrasound-guided suprazygomatic maxillary nerve block (SMNB) will be performed in paediatric patients with or without the aid of ultrasound guidance. Magnetic resonance imaging (MRI) is used to visualize the spread of the local anaesthetic (LA) spread after suprazygomatic injection and to verify LA contact with the maxillary nerve in the pterygopalatine fossa (PPF).

Interventions

OTHERNerve block

Suprazygomatic maxillary nerve block

Sponsors

Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
10 Months to 24 Months
Healthy volunteers
No

Inclusion criteria

* Paediatric patients scheduled for cleft palate (CP) surgery with SMNB as part of their perioperative pain treatment * American Society of Anesthesiologists physical status 1 - 2 * Age 10 to 24 months * Given informed written consent by legal guardian

Exclusion criteria

* American Society of Anesthesiologists physical status \> 2 * Patients with cranial deformation * Patients with concomitant medical treatments or medical conditions interfering with peripheral nerve block treatment * Patients with concomitant medical treatments or medical conditions interfering with MRI * Patients that are allergic to bupivacaine or other local anaesthetic agents.

Design outcomes

Primary

MeasureTime frameDescription
Rate of LA spread into the PPFday one - within an hour after intervention (peripheral nerve block)Local anesthetic spread to the maxillaris nerve in the pterygopalatine fossa detected by MRI (binary outcome)

Secondary

MeasureTime frameDescription
Rate of hematomaday one - within an hour after intervention (peripheral nerve block)Accumulation of blood detected by MRI (binary outcome)
Superior-inferior needle angleday one - immediately after intervention (peripheral nerve block)Angle of the injection needle meassured in a coronal plane
Anterior-posterior needle angleday one - immediately after intervention (peripheral nerve block)Angle of the injection needle meassured in a sagittal plane
Rate of LA spread to other anatomical areas and structuresday one - within an hour after intervention (peripheral nerve block)Local anaesthetic spread to orbita, nasal cavity, cranial fossa, infratemporal fossa, or other structures detected by MRI (binary outcome)
Side effects and adverse eventsday oneAll side effects or adverse events that might be detected
Postoperative analgesic consumptionday one and day twoOpioid consumption during the first 24 hours after surgery
MRI timeday oneTime consumption for MRI
Needle depthday one - immediately after intervention (peripheral nerve block)Depth of the injection needle

Countries

Norway

Contacts

Primary ContactAxel Sauter, MD PhD
axsa@online.no93484022
Backup ContactNergis Suleiman, MD
nergis.nina.suleiman@gmail.com23070000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026